Lobe Sciences Ltd Ordinary Shares GTSIF

Healthcare Drug Manufacturers - Specialty & Generic

Lobe Sciences Ltd is a technology and services company that provides real estate, financial, management, IP, and branding support for the development of transformational medicine. It is working to develop effective psilocybin-based therapeutics for the treatment of mild traumatic brain injuries and post-traumatic stress disorder and devices for the efficient application of medications.

OTCPK:GTSIF - Post by User

Lobe Sciences Ltd Ordinary Shares > NEWS: Roadmap for Remainder of 2022 & Early 2023 𓋼𓋺𓋼

<< Previous

Bullboard Posts

Next >>

Comment by Marcinon Jun 16, 2022 12:45pm

138 Views

Post# 34761738

RE:NEWS: Roadmap for Remainder of 2022 & Early 2023 𓋼𓋺𓋼

initforthemush wrote: Newsfile Corp. - June 14, 2022) - Lobe Sciences Ltd. (CSE: LOBE) Lobe is preparing a pre-IND meeting request with the US Food and Drug Administration (FDA) to confirm its regulatory strategy and Phase I clinical protocols. We expect to have this meeting in the 3rd quarter of 2022.

" I look forward to keeping our shareholders informed as the year unfolds "
--- Philip J Young, CEO

Looks like it's going to run soon

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?